A First-in-Human Study of RGT-075, a Novel, Orally Bioavailable, Small-Molecule GLP-1 Receptor Agonist, in Healthy Adult Subjects

被引：0
|
作者：
Pirner, Mark A.
Lin, Jing
Liu, Feng
Yao, Lili
Zettler, Marjorie E.
Valacer, David J.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-724-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
724-P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
    Winkle, Peter
    Goldsmith, Steven
    Koren, Michael J.
    Lepage, Serge
    Hellawell, Jennifer
    Trivedi, Ashit
    Tsirtsonis, Kate
    Abbasi, Siddique A.
    Kaufman, Allegra
    Troughton, Richard
    Voors, Adriaan
    Hulot, Jean-Sebastien
    Donal, Erwan
    Kazemi, Navid
    Neutel, Joel
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (04) : 743 - 755
  • [12] A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
    Peter Winkle
    Steven Goldsmith
    Michael J. Koren
    Serge Lepage
    Jennifer Hellawell
    Ashit Trivedi
    Kate Tsirtsonis
    Siddique A. Abbasi
    Allegra Kaufman
    Richard Troughton
    Adriaan Voors
    Jean-Sebastien Hulot
    Erwan Donal
    Navid Kazemi
    Joel Neutel
    Cardiovascular Drugs and Therapy, 2023, 37 : 743 - 755
  • [13] Discovery of a Potent, Orally Efficacious Small Molecule Agonist of Glucagon-Like Peptide-1 (GLP-1) Receptor
    Bearss, David J.
    Lin, Chenyu
    Medley, Kyle
    Vankayalapati, Hariprasad
    DIABETES, 2024, 73
  • [14] First-in-Human Single and Multiple Dose Study of the Dual GLP-1/GIP Agonist VK2735 in Healthy Adults
    Lian, Brian
    Mancini, Marianne
    Ji, Summer
    Barker, Geoff
    Neutel, Joel
    Rowland, Angela
    Bell, Francesca
    Rooney, Carmela
    Steele, Becky
    OBESITY, 2023, 31 : 41 - 42
  • [15] First-in-Human Study of an Oral Formulation of the GLP-1/GIP Co-Agonist VK2735 in Healthy Adults
    Neutel, Joel
    Rowland, Angela
    Bell, Francesca
    Rooney, Carmela
    Rask, Chris
    Steele, Becky
    Ji, Summer
    Barker, Geoff
    Mancini, Marianne
    Lian, Brian
    OBESITY, 2024, 32 : 61 - 62
  • [16] First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases
    Helmer, Eric
    Watling, Mark
    Jones, Emma
    Tytgat, Dominique
    Jones, Mark
    Allen, Rodger
    Payne, Andrew
    Koch, Annelize
    Healy, Eugene
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 581 - 591
  • [17] First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases
    Eric Helmer
    Mark Watling
    Emma Jones
    Dominique Tytgat
    Mark Jones
    Rodger Allen
    Andrew Payne
    Annelize Koch
    Eugene Healy
    European Journal of Clinical Pharmacology, 2017, 73 : 581 - 591
  • [18] Efficacy of CT-996, an Oral Small Molecule GLP-1 Receptor Agonist, in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus Monkeys
    Luo, Jian
    Rodriguez, Ruben
    Hergarden, Anne
    Tracy, Ted
    Lam, Davina
    Garai, Sumanta
    Marshall, Dan
    Hansen, Stig K.
    Chakravarthy, Manu
    DIABETES, 2024, 73
  • [19] First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects
    Chen, Rui
    Guan, Xiaoduo
    Hu, Pei
    Dong, Yanli
    Zhu, Yi
    Zhang, Tengfei
    Zou, Jianjun
    Zhang, Shuyang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [20] Effects of the GLP-1 receptor agonist liraglutide on human peripheral immune cells from healthy subjects in vitro and in vivo
    Bock, G.
    Prietl, B.
    Tauschmann, M.
    Hoeller, E.
    Neuper, C.
    Graninger, W.
    Pieber, T. R.
    DIABETOLOGIA, 2012, 55 : S191 - S191
12345